Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

Personalizing Care for HER2-Positive Gastric/GEJ Cancers Based on New Evidence

Friday, July 1, 2022

13:55 – 14:25

Location: Rooms 111-112; Level 1

Session Speaker(s)

Yelena Y. Janjigian, MD

Memorial Sloan Kettering Cancer Center
New York, United States

Supported by Daiichi